Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys Monotherapy in Chronic Hepatitis C Patients with End-Stage Renal Disease on Hemodialysis
NCT02806505Phase 3Completed
- Sponsor
- Roche
- Start
- Jun 2004
- Primary completion
- Aug 2007
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 8
01
Overview
A Phase 3 trial of peginterferon alfa-2a in hepatitis C (HCV), sponsored by Roche. Started Jun 2004; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02806505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02806505.